Biostatistics-Driven RTSM: Unbiased Assessment of Outcomes in Clinical Trials
Randomization and Supply management (RTSM) needs to be built and deployed rapidly, so that your clinical trial can start faster. To reach that speed, you need a user-friendly and state-of-the-art RTSM platform that combines a fast set-up time with the flexibility of customized programming.
With IDDI’s Randomization and Supply management (RTSM) or IRT platform, you are able to automate and simplify the implementation of any complex randomization scheme. Our fully integrated and configurable RTSM/IRT platform, combined with our RTSM-minded expert biostatisticians, keep your trial on the path to success.
- Our biostatisticians not only provide the most appropriate randomization methodology to meet your trial’s specific needs, they help customize your study and program goals thanks to their deep knowledge of regulatory guidelines, methodologies, and study design strategies. There is always a statistician involved to check balance on a regular basis during study conduct.
- The IRT/RTSM is fully integrated with our EDC system, can be easily plugged into other EDC solutions and drug-supply distributors’ systems, and is adjustable throughout the clinical trial with no downtime.
Our Randomization and Supply Management (RTSM) System Supports all Types of Randomization Schemes
- Our expert team of biostatisticians and IWRS programmers provide fixed, dynamic, multi-stage and adaptive randomization methods using IDDI’s in-house developed web-based central randomization and drug supply Management system (IRT/RTSM) (ID-net™)
- Methods such as stratified permuted block randomization and stochastic minimization are used to balance for prognostic factors, and many other allocation schemes can also be implemented.
READ: CENTRALIZED TREATMENT ALLOCATION IN COMPARATIVE CLINICAL TRIALS Marc Buyse